Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
- PMID: 36060008
- PMCID: PMC9434632
- DOI: 10.3389/fphar.2022.976792
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
Abstract
[This corrects the article DOI: 10.3389/fphar.2022.896971.].
Keywords: carbapenem-resistant; cefiderocol; gram-negative bacteria; multidrug resistant; systematic review.
Copyright © 2022 Frontiers Production Office.
Erratum for
-
Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence.Front Pharmacol. 2022 Apr 12;13:896971. doi: 10.3389/fphar.2022.896971. eCollection 2022. Front Pharmacol. 2022. PMID: 35496290 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
